SABCS 2020: Radiation Side-Effects Often Underrecognized in Patients With Breast Cancer
Acute side-effects of radiation therapy (RT) are often underrecognized by the physicians of...
Read MoreDec 18, 2020
Acute side-effects of radiation therapy (RT) are often underrecognized by the physicians of...
Read MoreDec 18, 2020
An online tool (RSClin) incorporating clinical-pathologic data and results of the 21-gene...
Read MoreDec 18, 2020
Meeting Brief… A subgroup of patients participating in the randomized phase III NALA study...
Read MoreDec 18, 2020
The omission of radiotherapy (RT) does not affect overall survival at 10 years after breast...
Read MoreDec 18, 2020
Pregnancy is less likely after prior breast cancer (BC) diagnosis, according to a systematic...
Read MoreDec 15, 2020
MONDAY, Dec. 14, 2020 (HealthDay News) — Pregnancy is less likely after prior breast cancer...
Read MoreDec 11, 2020
Addition of selinexor to bortezomib and dexamethasone reduces neuropathy The triple combination of...
Read MoreDec 11, 2020
Projection shows increases by lines of therapy Physicians treating multiple myeloma can expect to...
Read MoreDec 10, 2020
HBM9036 ophthalmic solution 0.25%, also known as tanfanercept, a novel TNF-α inhibitor, is safe and effective for improving certain symptoms of dry eye disease, according to results of a phase 2 randomized, a double-blind...
Read MoreDec 10, 2020
Contributing to this article, Shahzad I. Mian, MD, Professor, Ophthalmology and Visual Sciences, Vice Chair, Clinical Sciences and Learning, Kellogg Eye Center, Michigan Medicine Previous research has shown that patients...
Read MoreDec 10, 2020
Reaching RAPID3 and cDAPSA Treatment Targets Linked with Active PsA Control in DMARD-naïve Patients Treated with Apremilast Disease-modifying anti-rheumatic drug (DMARD)-naïve patients achieving Routine Assessment of Patient...
Read MoreDec 10, 2020
Results from Phase 2 PoS Trial In patients with active psoriatic arthritis (PsA) , deucravacitinib was efficacious versus placebo (PBO) over 16 weeks of treatment. Treatment was well tolerated and the safety profile was...
Read MoreDec 9, 2020
New research was presented at FMX 2020, the 2020 American Academy of Family Physicians virtual...
Read MoreDec 4, 2020
The results of CONTESSA, a Phase 3 study of tesetaxel in the treatment of patients with metastatic breast cancer, have been selected for an oral presentation at the 2020 SABCS, to be held virtually December 8-11, 2020. The...
Read MoreDec 4, 2020
Homologous recombination deficiency represents a new therapeutic strategy for breast cancer brain metastases Nicola S Cosgrove BACKGROUND: Brain metastatic disease occurs in 10-30% of metastatic breast cancer cases. The...
Read MoreDec 4, 2020
The collaborative Phase 3 PENELOPE-B will be presented at SABCS 2020. No unexpected safety signals were observed. Phase 3 PENELOPE-B trial did not meet the primary endpoint of improved invasive disease-free survival (iDFS) in...
Read MoreDec 4, 2020
New Data for HER2 and HER3 Directed DXd ADCs at SABCS includes longer follow-up research data for ENHERTU® based on DESTINY-Breast01, including updated duration of response, progression-free survival, an 18-month landmark...
Read MoreDec 4, 2020
The 43rd Virtual San Antonio Breast Cancer Symposium (SABCS®) will take place from December 8-11, 2020. The SABCS is the premier conference for basic, translational, and clinical cancer research professionals. It is well-known...
Read MoreNov 25, 2020
At the European Society for Medical Oncology (ESMO) Virtual Congress 2020 , lead study investigator Prof. Byoung Chul Cho (Yonsei Cancer Centre, Yonsei University College of Medicine in Seoul, South Korea) presented the interim...
Read MoreNov 23, 2020
A retrospective study of transgender people using gender-affirming hormone therapy (GAHT) found...
Read More